Luminist Capital’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Luminist Capital’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$272	Hold	1	–	–	﹤0.01%	369
2026 Q2	$248	Buy	+1	New	+$215	﹤0.01%	389
2026 Q1	–	Sell	-1	Closed	-$207	–	152
2025 Q4	$207	Hold	1	–	–	﹤0.01%	266
2025 Q3	$185	Hold	1	–	–	﹤0.01%	326
2025 Q2	$162	Hold	1	–	–	﹤0.01%	334
2025 Q1	$164	Hold	1	–	–	﹤0.01%	242
2024 Q4	$166	Buy	+1	New	+$171	﹤0.01%	232

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $170B AUM 38.25% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $375B AUM 21.05% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $121B AUM 21.47% 1-Year Est. Return

Berger Financial Group Plymouth, Minnesota $2.01B AUM 15.82% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return

Nilsine Partners Greenwood Village, Colorado $1.44B AUM 38.08% 1-Year Est. Return

Summit Financial Parsippany, New Jersey $9.42B AUM 19.31% 1-Year Est. Return

D.A. Davidson & Co Great Falls, Montana $18.6B AUM 17.65% 1-Year Est. Return

Luminist Capital's FBT Position: Q3 2026 in Review

Luminist Capital held its First Trust NYSE Arca Biotechnology Index Fund (FBT) position steady in Q3 2026 at 1 share worth $272. The position accounts for ﹤0.01% of the portfolio, ranked #369.

Luminist Capital first reported a position in FBT in Q4 2024 and has held it in 7 quarters since. 272 funds tracked by Wall St. Rank hold FBT as of Q3 2026.

Luminist Capital held 1 share of First Trust NYSE Arca Biotechnology Index Fund worth $272 as of Q3 2026.
Luminist Capital left its First Trust NYSE Arca Biotechnology Index Fund share count unchanged in Q3 2026.
First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of Luminist Capital's portfolio in Q3 2026, its #369 holding.
Luminist Capital first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2024 and has held it in 7 quarters since.
272 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2026.

Based on Luminist Capital's 13F filing for Q3 2026, filed 10 Nov 2026.